Abstract
Purpose:
This study observed biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus in contact lens cases and investigated the inhibitory effects of 2,2′-dipyridyl (2DP) and 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose (PGG).
Methods:
Biofilm formation of P. aeruginosa ATCC 9027 and S. aureus ATCC 25923 and ATCC 6538 in contact lens cases was determined for a range of initial inocula and incubation times using crystal violet staining. The effects of 2DP and PGG on biofilm were evaluated alone and in combination by their incorporation into the media at commencement of incubation.
Results:
At 24 hours, biofilm production was related to initial concentration. However, with extended incubation, higher initial concentrations affected formation in S. aureus. Presence of 312 μM 2DP significantly inhibited P. aeruginosa biofilm formation, but had little effect on that of S. aureus. In contrast, PGG (50 μM) inhibited S. aureus biofilm formation, but had much less effect on that of P. aeruginosa. Combination of the agents effectively inhibited biofilm formation of all three organisms throughout a week-long incubation period with OD levels barely exceeding cell-free controls.
Conclusions:
Biofilm formation of P. aeruginosa could be prevented by 2DP, while biofilm formation of S. aureus was inhibited by PGG. However, combining these agents showed better inhibition of biofilm production than use of either agent alone on both species. This combination may be useful in prevention of biofilm in contact lens cases, thereby reducing infection risk due to poor compliance with lens case cleaning and replacement. Further work is needed to confirm compatibility with multipurpose solutions and investigate cytotoxicity to ocular tissues.
Microbial keratitis is a rare, but a sight-threatening complication associated with contact lens wear.
1 Pseudomonas aeruginosa and
Staphylococcus aureus are common pathogens associated with microbial keratitis,
2,3 and may be isolated from used contact lens cases.
2,4,5 Noncompliance in contact lens wear leads to contamination of the lenses and accessories, in particular the lens cases, and is a major obstacle to safe contact lens wear.
1,5–7 High rates of contamination of contact lens cases have been reported in users of both soft and rigid lenses.
7–9
Commercially available contact lens multipurpose solutions to be approved by the US Food and Drug Administration (FDA) have to achieve at least a 3-log reduction of cell viability of three strains of bacteria designated in the FDA guidelines:
S. aureus ATCC 6538,
Serratia marcescens ATCC 13880, and
P. aeruginosa ATCC 9027.
10 Some multipurpose solutions have been shown to have activity against other organisms, including clinical isolates.
11 However, the FDA testing method only requires solutions to be active against planktonic bacteria,
10 but both
P. aeruginosa and
S. aureus can form biofilms on surfaces of medical devices.
12,13
The formation of a biofilm involves the attachment and accumulation of bacterial cells on a solid surface.
12 Organisms in the biofilm have been shown to be more resistant to killing by disinfectants and other antimicrobial agents through several mechanisms, such as reducing access of toxic agents to the cells within the biofilm, production of neutralizing chemicals, gene mutation or genetic exchange between cells in the biofilm, and cells with lower metabolic rate.
14,15 Szczotka-Flynn et al.
16 demonstrated that some multipurpose solutions (MPS) used currently had little to no effect (log reduction less than 1) on the biofilms of
P. aeruginosa,
S. marcescens, and
S. aureus.
Iron is an essential nutrient for bacterial growth and is crucial for bacterial energy production, nucleotide synthesis, and regulation of gene expression.
17 Iron regulation of biofilm formation has been demonstrated in many bacterial species.
17,18 As in many other bacteria, the ferric uptake regulator protein in
P. aeruginosa plays a major role in biofilm development as a global regulator of iron-responsive genes.
19 Singh et al.
20 demonstrated that iron acted as an environmental signal for the development of
P. aeruginosa biofilm that can be restricted by lactoferrin, an iron chelator. In
S. aureus, iron is also required for biofilm formation.
21
Iron-chelating agents 2,2′-dipyridyl (2DP) and 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose (PGG) have been shown to inhibit biofilm formation on smooth surfaces by
S. aureus and
P. aeruginosa.
17,22 To facilitate contact lens removal from lens case wells, most lens case designs include ridges on the surface of the wells. These ridges make the cases more difficult to clean, facilitating biofilm formation.
The purpose of this study was to investigate the formation of biofilm by incubation of
S. aureus and
P. aeruginosa in the contact lens cases and the effects of 2DP and PGG against such biofilm formation. Two strains of
S. aureus were utilized as they differ in their ability to produce biofilms, which is related to their production of exopolysaccharides.
23
The iron chelators used were 2DP and PGG, which were purchased from Sigma-Aldrich Corporation (St. Louis, MO, USA), dissolved in phosphate buffered saline, and used over a range of concentrations (0–2500 and 0–50 μM, respectively).
Statistical analyses were performed using statistical software (SPSS system for Windows version 16.0; SPSS, Inc., Chicago, IL, USA). An unpaired t-test was used to compare the amount of biofilm formed between control and inhibitors, alone and in combination, as well as between inhibitors alone and in combination. A value of P < 0.05 was considered significant.
Supported by an internal grant from the School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong. The authors alone are responsible for the content and writing of the paper.
Disclosure: P. Cho, None; G.-S. Shi, None; M. Boost, None